A review on COVID-19 transmission, epidemiological features, prevention and vaccination

Author:

Zhang Yuqin1ORCID,Wu Gonghua1,Chen Shirui1,Ju Xu1,Yimaer Wumitijiang1,Zhang Wangjian1,Lin Shao2,Hao Yuantao13,Gu Jing1,Li Jinghua1

Affiliation:

1. School of Public Health, Sun Yat-Sen University , Guangzhou , China

2. Department of Environmental Health Sciences , School of Public Health, University at Albany, State University of New York , Rensselaer , NY , USA

3. Sun Yat-Sen University Global Health Institute, School of Public Health and Institute of State Governance, Sun Yat-Sen University , Guangzhou , China

Abstract

Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused hundreds of millions of infections and millions of deaths over past two years. Currently, many countries have still not been able to take the pandemic under control. In this review, we systematically summarized what we have done to mitigate the COVID-19 pandemic, from the perspectives of virus transmission, public health control measures, to the development and vaccination of COVID-19 vaccines. As a virus most likely coming from bats, the SARS-CoV-2 may transmit among people via airborne, faecal-oral, vertical or foodborne routes. Our meta-analysis suggested that the R0 of COVID-19 was 2.9 (95% CI: 2.7–3.1), and the estimates in Africa and Europe could be higher. The median Rt could decrease by 23–96% following the nonpharmacological interventions, including lockdown, isolation, social distance, and face mask, etc. Comprehensive intervention and lockdown were the most effective measures to control the pandemic. According to the pooled R0 in our meta-analysis, there should be at least 93.3% (95% CI: 89.9–96.2%) people being vaccinated around the world. Limited amount of vaccines and the inequity issues in vaccine allocation call for more international cooperation to achieve the anti-epidemic goals and vaccination fairness.

Publisher

Walter de Gruyter GmbH

Reference180 articles.

1. Peeri, NC, Shrestha, N, Rahman, MS, Zaki, R, Tan, Z, Bibi, S, et al.. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol 2020;49:717–26. https://doi.org/10.1093/ije/dyaa033.

2. International Expert Meeting on the Treatment of SbTCM, the Integration of Traditional Chinese Medicine with Western M. SARS: clinical trials on treatment using a combination of traditional Chinese medicine and Western medicine: report of the WHO International Expert Meeting to review and analyse clinical reports on combination treatment for SARS, 8–10 October 2003. Beijing, People’s Republic of China. In. Geneva: World Health Organization; 2004.

3. WHO. Middle East respiratory syndrome coronavirus (MERS-CoV). Available from: https://www.who.int/health-topics/middle-east-respiratory-syndrome-coronavirus-mers#tab=tab_1 [Accessed 4 Apr 2021].

4. Al-Omari, A, Rabaan, AA, Salih, S, Al-Tawfiq, JA, Memish, ZA. MERS coronavirus outbreak: implications for emerging viral infections. Diagn Microbiol Infect Dis 2019;93:265–85. https://doi.org/10.1016/j.diagmicrobio.2018.10.011.

5. Zhu, N, Zhang, D, Wang, W, Li, X, Yang, B, Song, J, et al.. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727–33. https://doi.org/10.1056/nejmoa2001017.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3